Evaluation of magnetic micro- and nanoparticle toxicity to ocular tissues

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Raju, Hemalatha B ^a   Hu, Ying ^a   Vedula, Anil ^a   Dubovy, Sander R ^a   Goldberg, Jeffrey L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; FERRIC FERROCYANIDE; FERROCYANIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; IRON; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ELECTRORETINOGRAM; ENDOTHELIUM CELL; EYE TOXICITY; GLIA CELL; HISTOLOGY; IMMUNOFLUORESCENCE; INTRAOCULAR PRESSURE; IRON STORAGE; MORPHOLOGY; NONHUMAN; PHOTORECEPTOR; RAT; ANIMAL; ASTROCYTE; CELL COUNT; CELL SURVIVAL; DRUG EFFECT; ELECTRORETINOGRAPHY; EYE; IMMUNOHISTOCHEMISTRY; MAGNETISM; METABOLISM; MICROGLIA; PARTICLE SIZE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STAINING;

ANIMALIA; RATTUS;

ANIMALS; ASTROCYTES; CELL COUNT; CELL SURVIVAL; ELECTRORETINOGRAPHY; EYE; FERROCYANIDES; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; IRON; MAGNETICS; MICROGLIA; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING;

EID: 79957557933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017452     Document Type: Article

References (22)

1. Raju HB, Goldberg JL, (2008) Nanotechnology for ocular therapeutics and tissue repair. Expert Review of Ophthalmology 3: 431-436.
2. Oweida AJ, Dunn EA, Foster PJ, (2004) Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide. Mol Imaging 3: 85-95.
3. Gallo JM, Hafeli U, (1997) Correspondence re: A.S. Lubbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 56: 4694-4701 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996: Letter. Cancer Res 57: 3063-3065.
4. Lubbe AS, Alexiou C, Bergemann C, (2001) Clinical applications of magnetic drug targeting. J Surg Res 95: 200-206.
5. Schutt W, Gruttner C, Hafeli U, Zborowski M, Teller J, et al. (1997) Applications of magnetic targeting in diagnosis and therapy-possibilities and limitations: a mini-review. Hybridoma 16: 109-117.
6. Bausch AR, Moller W, Sackmann E, (1999) Measurement of local viscoelasticity and forces in living cells by magnetic tweezers. Biophys J 76: 573-579.
7. Bausch AR, Ziemann F, Boulbitch AA, Jacobson K, Sackmann E, (1998) Local measurements of viscoelastic parameters of adherent cell surfaces by magnetic bead microrheometry. Biophys J 75: 2038-2049.
8. Potts, (1972) Electrophysiological measurements, In: Potts AM, editors. The Assessment of Visual Function St Louis CV Mosby Co.
9. Declercq SS, Meredith PC, Rosenthal AR, (1977) Experimental siderosis in the rabbit: correlation between electroretinography and histopathology. Arch Ophthalmol 95: 1051-1058.
10. Knave, (1969) Electroretinography in eyes with retained intraocular metallic foreign bodies. Acta Ophthalmol 100 (suppl).
11. Hu Y, Cho S, Goldberg JL, (2010) Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest Ophthalmol Vis Sci 51: 1747-1754.
12. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ, (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19: 975-983.
13. Bakri SJ, Pulido JS, Mukherjee P, Marler RJ, Mukhopadhyay D, (2008) Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina 28: 147-149.
14. Hafeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, et al. (2009) Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery. Mol Pharm.
15. Lattuada M, Hatton TA, (2007) Functionalization of monodisperse magnetic nanoparticles. Langmuir 23: 2158-2168.
16. Chang JS, Chang KL, Hwang DF, Kong ZL, (2007) In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 41: 2064-2068.
17. Lacava LM, Lacava ZG, Da Silva MF, Silva O, Chaves SB, et al. (2001) Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J 80: 2483-2486.
18. Lacava ZGM, Garcia VAP, Lacava LM, Azevedo RB, Silva O, et al. (2004) Biodistribution and biocompatibility investigation in magnetoliposome treated mice. Spectroscopy 18: 597-603.
19. Peter PA, Lyda W, Krishna N, (1957) Anterior chamber perfusion studies. II. Controlled particle size in relationship to pore size. Am J Ophthalmol 44: 198-204; discussion 205-196.
20. Sappington RM, Carlson BJ, Crish SD, Calkins DJ, (2010) The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci 51: 207-216.
21. Meyer LA, Ubels JL, Edelhauser HF, (1988) Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment. Invest Ophthalmol Vis Sci 29: 940-948.
22. Sha O, Kwong WH, (2006) Postnatal Developmental Changes of Vitreous and Lens Volumes in Sprague-Dawley Rats. Neuroembryology and Aging 4: 183-188.